Related Experiment Videos
Atherogenesis and the arginine hypothesis.
1Section of Vascular Medicine, Stanford University School of Medicine, CVRB Section, Floor South, Stanford, CA, 94305-5406, USA. John.Cooke@stanford.edu
Current Atherosclerosis Reports
|April 5, 2001
Summary
Elevated asymmetric dimethylarginine (ADMA) in plasma is linked to a deficiency in L-arginine, contributing to atherosclerosis. This discovery offers new therapeutic strategies for cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Biochemistry
- Medical Research
Background:
- Atherosclerosis is a complex cardiovascular disease.
- Elevated plasma levels of ADMA are observed in patients with atherosclerosis.
- The role of L-arginine deficiency in atherosclerosis pathophysiology requires further elucidation.
Purpose of the Study:
- To investigate the relationship between plasma ADMA levels and L-arginine deficiency in atherosclerosis.
- To understand the contribution of L-arginine deficiency to the pathophysiology of atherosclerosis.
Main Methods:
- Analysis of plasma ADMA levels.
- Assessment of L-arginine status in patients with atherosclerosis.
- Correlation studies between ADMA, L-arginine, and atherosclerotic markers.
Main Results:
- A relative deficiency of L-arginine was identified in patients with elevated plasma ADMA.
- This L-arginine deficiency contributes to vasoconstriction.
- The findings indicate accelerated atherogenesis in the context of ADMA elevation and L-arginine deficiency.
Conclusions:
- The relative deficiency of L-arginine in atherosclerotic disease is a significant finding.
- This breakthrough opens new therapeutic avenues for treating atherosclerosis.
- Targeting L-arginine levels may be a promising strategy for cardiovascular disease therapy.